Cardiac Ablation Companies, Corporate Growth and Development Strategy

Top Companies in the Cardiac Ablation Market

• Biosense Webster
• Abbott Laboratories
• Boston Scientific
• Medtronic
• Philips Healthcare
• Siemens Healthineers
• Stereotaxis
• Acutus Medical
• AtriCure
• CardioFocus
• Affera
• Farapulse/Boston Scientific
• IntellaMed/Corindus
• MicroPort/Lepu Medical
• Biotronik
• Cook Medical
• Merit Medical Systems
• Rhythmia
• EPD/EP-lab software vendors
• Startups & innovators

Market Growth

The global cardiac ablation market size is calculated at US$ 5.15 billion in 2024, grew to US$ 5.88 billion in 2025, and is expected to increase around US$ 19.44 billion by 2034. The market is expanding at a CAGR of 14.24% between 2025 and 2034.

What are the Key Trends in the Cardiac Ablation Market?

The growing cases of cardiac arrhythmias like atrial fibrillation and ventricular tachycardia, and ongoing technological advances are acting as key growth factors in the respective market expansion.

• In August 2025, Virtual ward and remote monitoring technology provider Doccla partnered with Happitech to bring remote monitoring of atrial fibrillation (AF) to UK homes.
• In July 2025, Kardium Inc., the developer of the Globe Pulsed Field System, a groundbreaking treatment for atrial fibrillation (AF), raised US$250 million in a new financing round.
• In April 2025, Field Medical Inc., an innovator in cardiac pulsed field ablation (PFA) technology, successfully closed $40 million in Series A financing to redefine pulsed field ablation for ventricular tachycardia.

Latest Announcements by Industry Leaders

In January 2025, IceCure Medical Ltd., a pioneer of minimally invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, announced it had submitted a regulatory filing with China's National Medical Products Administration ("NMPA") for the approval of its ProSense Cryoablation System. IceCure CEO, Eyal Shamir, commented that they are fostering a line of available products, also securing reimbursement, so that IceCure can be ideally positioned to serve this important geography.

Recent Developments in the Cardiac Ablation Market

• In September 2025, Steven Mickelsen, MD, introduced Del Medtech Inc., a seed-stage medical device company with a mission to advance minimally invasive ablation technology beyond cardiac care.
• In May 2025, Johnson & Johnson MedTech unveiled the Soundstar Crystal Ultrasound Catheter for intracardiac echocardiography (ICE) imaging in cardiac ablation procedures. 

Become a valued research partner with us, please feel free to contact us at sales@towardshealthcare.com